STOCK TITAN

TPPRF - $TPPRF STOCK NEWS

Welcome to our dedicated page for TPPRF news (Ticker: $TPPRF), a resource for investors and traders seeking the latest updates and insights on TPPRF stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TPPRF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TPPRF's position in the market.

Rhea-AI Summary
Vencanna Ventures Inc. announces a name change and a definitive unit exchange agreement with Cannavative Group LLC, resulting in less dilution. The Transaction includes the acquisition of all outstanding membership units of Cannavative through an all-share exchange. The company will issue exchangeable shares, share purchase warrants, and earn-out units. Additionally, a convertible debenture will be converted into common shares and share purchase warrants. The Transaction will result in Vencanna having approximately 279.0 million shares outstanding, debt-free with C$4.0 million in cash. The Transaction value is US$8.1 million. The company's shares will resume trading under the symbols VENI and TPPRF. The acquisition of Cannavative positions Vencanna in the U.S. cannabis market, aligning with ongoing developments in New Jersey. The company aims to expand market penetration in Nevada and explore investment opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Vencanna Ventures reports financial results for Q3 2023, recording a net loss of $196,805 compared to $96,853 in Q3 2022. Revenues for Q2 2023 were $40,815. The company is involved in US cannabis-related activities, with 57% of its assets directly related to this sector. The Secure and Fair Enforcement Regulation (SAFER) Banking Act passed the Senate Banking Committee, a critical step towards a senate vote. HHS recommended moving cannabis from Schedule I to Schedule III, potentially reducing tax burden for compliant businesses. The company amended its definitive agreement with Cannavative, acquiring all membership units. The transaction is expected to close in late October or early November 2023. The company continues to make progress in its New Jersey partnerships, securing licenses and sites for operations. The NCIB has been renewed, allowing the company to repurchase up to 5% of its shares.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Vencanna Ventures announces a transaction with The Cannavative Group to acquire all its membership units. The transaction includes the issuance of common shares, share purchase warrants, and earn-out units. Vencanna's debt will also convert into shares and warrants. The completion of the transaction is subject to approval from the Canadian Securities Exchange (CSE) and Vencanna's shareholders. The company plans to expand into New Jersey and other potential markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
TPPRF

OTC:TPPRF

TPPRF Rankings

TPPRF Stock Data

8.45M
146.63M
18.49%
Drug Manufacturers—Specialty & Generic
Healthcare
Link
Canada
Calgary